TNF-alpha inhibitors in organ transplant recipients: a retrospective cohort study
Arch Dermatol Res
.
2024 May 17;316(5):179.
doi: 10.1007/s00403-024-02944-y.
Authors
Christopher Madden
1
2
,
Katherine G Thompson
3
,
Isabelle T Smith
1
4
,
Jacqueline Ike
1
5
,
Briana R Halle
1
6
,
Carolyn Ahlers
7
,
Dominique Mosley
1
,
Sarah Grossarth
8
,
Kristin Bibee
3
,
Lee Wheless
9
10
11
Affiliations
1
Department of Dermatology, Vanderbilt University Medical Center (VUMC), Nashville, TN, USA.
2
State University of New York Downstate College of Medicine, Brooklyn, NY, USA.
3
Johns Hopkins Department of Dermatology, Baltimore, MD, USA.
4
Vanderbilt University, Nashville, TN, USA.
5
Meharry Medical College, Nashville, TN, USA.
6
Department of Dermatology, University of California Irvine, Irvine, CA, USA.
7
Department of Dermatology, Duke University, Durham, NC, USA.
8
Quillen College of Medicine, Johnson City, TN, USA.
9
Department of Dermatology, Vanderbilt University Medical Center (VUMC), Nashville, TN, USA. lee.e.wheless@vumc.org.
10
Tennessee Valley VA Medical Center, Nashville, TN, USA. lee.e.wheless@vumc.org.
11
VUMC Department of Medicine, Division of Epidemiology, Nashville, TN, USA. lee.e.wheless@vumc.org.
PMID:
38758401
DOI:
10.1007/s00403-024-02944-y
No abstract available
Publication types
Multicenter Study
Letter
MeSH terms
Adult
Aged
Cohort Studies
Female
Humans
Male
Middle Aged
Organ Transplantation*
Retrospective Studies
Tumor Necrosis Factor Inhibitors* / adverse effects
Substances
Tumor Necrosis Factor Inhibitors
Grants and funding
CX-002452/U.S. Department of Veterans Affairs
Physician Scientist Career Development Award/Dermatology Foundation